Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Equity Income (2022 - 2025)

Agilon Health (AGL) has disclosed Equity Income for 4 consecutive years, with -$33.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Income fell 1126.87% year-over-year to -$33.1 million, compared with a TTM value of -$1.8 million through Dec 2025, down 112.24%, and an annual FY2025 reading of -$1.8 million, down 112.24% over the prior year.
  • Equity Income was -$33.1 million for Q4 2025 at Agilon Health, down from $13.1 million in the prior quarter.
  • Across five years, Equity Income topped out at $14.7 million in Q3 2023 and bottomed at -$33.1 million in Q4 2025.
  • Average Equity Income over 4 years is $1.9 million, with a median of $5.4 million recorded in 2025.
  • Peak annual rise in Equity Income hit 541.57% in 2025, while the deepest fall reached 1126.87% in 2025.
  • Year by year, Equity Income stood at -$4.3 million in 2022, then tumbled by 85.86% to -$8.0 million in 2023, then skyrocketed by 66.4% to -$2.7 million in 2024, then plummeted by 1126.87% to -$33.1 million in 2025.
  • Business Quant data shows Equity Income for AGL at -$33.1 million in Q4 2025, $13.1 million in Q3 2025, and $5.4 million in Q2 2025.